Our (Viewers Corner News) correspondent in London reported that coronavirus vaccine at final clinical trial which was developed by AstraZeneca and Oxford University has been put on hold after a volunteer falls ill. AstraZeneca stated that the action to pause the vaccine after the participant in United Kingdom had a suspected adverse reaction is a routine pause in the case of an unexplained illness. A lot of people worldwide were hoping that the AstraZeneca-Oxford University vaccine might be one of the first to be out in the market after its successful phase 1 and 2 testing. In phase 3 testing, about 30,000 volunteers from United States, United Kingdom, Brazil and South Africa were participated and vaccine’s phase 3 trials can last for several years. According to the report, the volunteer was diagnosed with transverse myelitis (an inflammatory syndrome that affects the spinal cord and can be caused by viral infections). independent investigation will find out if the disease has any link to the vaccine.
Source: Viewers Corner News.